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Editorial Comment
Implementing Results of Stroke Recovery Research Into Clinical Practice
Most patients show some recovery of deficits in the
weeks-months following a focal infarct. Numerous studies
have characterized the molecular, cellular, systems, and
behavioral level1–3 brain changes related to this recovery.
In the current article, Ilvonen et al,4 using mismatch
negativity (MMN), describe an evolution of brain physi-
ology that paralleled recovery of language. Consistent with
prior studies using functional MRI (fMRI)5 or positron
emission tomography (PET),6 these authors found changes
in brain function within both hemispheres as language
improved. Apart from new information on brain reorgani-
zation gained from this investigation, this report has
significance in at least 2 other ways: only passive patient
participation was needed to probe the brain, and the
methods employed can be easily implemented in thousands
of medical facilities worldwide.
MMN is a type of auditory-evoked potential that reflects
cerebral processing of changes in the acoustic environ-
ment. An auditory stimulus is presented while scalp
electrodes record cortical potentials. A change in the
auditory stimulus pattern is then introduced, which results
in a negative deflection over characteristic brain areas such
as frontal or temporal lobes. This deflection represents an
objective measure of auditory and language processing that
can be elicited in the absence of attention.7,8 MMN has
provided insights into brain function in a number of brain
states,9 including conditions in which studying brain phys-
iology can be otherwise difficult, such as schizophrenia10
and sleep.11
Most methods used to map brain function demand
cooperation from the patient being examined. Thus fMRI,
PET, and transcranial magnetic stimulation (TMS) study
paradigms require patients to actively perform a behavior
on cue. The need for such active participation narrows
entry criteria (a patient who cannot do the required
behavior on command cannot be in the study), and also
allows an influence on results by effort, fatigue, attention,
cooperation, comprehension, strategy, and other variables.
Even in healthy subjects, these variables can have a
substantial effect on brain mapping results. For example,
shifting the direction of gaze by 20° to 30° during right
finger movements modulates the volume of activation in
left primary motor cortex by 50%.12 The MMN brain
mapping approach employed by Ilvonen et al4 is limited in
several regards, such as spatial resolution. The authors do
not provide measures of intersubject variance. Also, addi-
tional studies are needed regarding the reliability of this
method in various stroke populations. Nevertheless, appli-
cation of MMN to patients with an evolving neurological
deficit is of particular value because this means of probing
brain function is little influenced by behavioral variables
such as attention.7,8
A broad range of molecular, cellular, physiotherapy, and
other treatments that target restorative brain events are
being developed to improve outcome after stroke. Will
these be administered in a one-size-fits-all approach, as
with aspirin after stroke? More likely, therapy will be
individualized on the basis of clinical data plus a measure
of the physiological target, as has been suggested when
selecting patients for revascularization or for acute neuro-
protective therapies. Examples of this approach in other
clinical practice settings include thyroxine dose based on
serum assessment of pituitary function and cardiac anti-ar-
rhythmia medication selection based on electrophysiolog-
ical laboratory studies.
Brain mapping studies employing fMRI, PET, or TMS
continue to provide new insights into how the brain changes
function in relation to neurological gains after stroke. However,
it is unlikely that such methods will enjoy broad application in
general neurological practice. If recovery-related processes are
to be measured in order to best implement future restorative
therapies, what techniques will be used?
Evoked potentials can currently be obtained in hospitals
around the world and have demonstrated clinical utility in
even complex medical settings. For example, the absence of
somatosensory-evoked potentials virtually ensures that a
patient with hypoxic-ischemic coma will not awaken.13
Evoked responses have been previously used to study stroke
recovery; however, the study by Ilvonen et al4 is important by
virtue of the number of physiological assessments over time
and inclusion of a valid behavioral measure. While a range of
investigative methods continue to be needed for a better
understanding of brain reformatting after stroke, a parallel
need exists to characterize accessible methods such as MMN
that might be used to reliably measure restorative events in
the day to day treatment of individual patients. The MMN
study by Ilvonen et al,4 in addition to further characterizing
return of language function after stroke, is an important step
toward this goal.
Steven C. Cramer, MD, Guest Editor
UCI Medical Center
Department of Neurology
University of California Irvine
Orange, California
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